Mesoporous silica-coated luminescent Eu3+ doped GdVO4 nanoparticles for multimodal imaging and drug delivery
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Taeho Kim | - |
dc.contributor.author | Lee N. | - |
dc.contributor.author | Yong Il Park | - |
dc.contributor.author | Jangwon Kim | - |
dc.contributor.author | Kim J. | - |
dc.contributor.author | Lee E.Y. | - |
dc.contributor.author | Yi M. | - |
dc.contributor.author | Kim B.-G. | - |
dc.contributor.author | Taeg Hwan Hyeon | - |
dc.contributor.author | Yu T. | - |
dc.contributor.author | Na H.B. | - |
dc.date.available | 2015-04-20T06:27:31Z | - |
dc.date.created | 2015-01-20 | - |
dc.date.issued | 2014-09 | - |
dc.identifier.issn | 2046-2069 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/1181 | - |
dc.description.abstract | We describe a simple method for synthesizing mesoporous silica-coated luminescent europium-doped gadolinium vanadate (GdVO4:Eu3+@mSiO2) nanoparticles. Their biomedical applications as a potential imaging nanoprobe for both fluorescence imaging and magnetic resonance imaging (MRI) and as a simultaneous anti-cancer drug delivery vehicle are also discussed. Eu3+ doped GdVO4 nanoparticles exhibit strong red photoluminescence and the Gd3+ in GdVO4 can be used as a T1 contrast agent for MRI. T1-weighted MR contrast enhancement as well as sustained intracellular drug delivery can be achieved by the mesoporous silica layer coating onto a single nanoparticle. Enhanced T1 MR contrast was proven by relaxometric studies on water access to the paramagnetic core. GdVO4:Eu3+@mSiO2 nanoparticles as a new type of theragnostic (imaging and treatment) agent can provide new opportunities in a cancer treatment. | - |
dc.language | 영어 | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.title | Mesoporous silica-coated luminescent Eu3+ doped GdVO4 nanoparticles for multimodal imaging and drug delivery | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.wosid | 000342761600008 | - |
dc.identifier.scopusid | 2-s2.0-84907818351 | - |
dc.identifier.rimsid | 16490 | ko |
dc.date.tcdate | 2018-10-01 | - |
dc.contributor.affiliatedAuthor | Taeho Kim | - |
dc.contributor.affiliatedAuthor | Yong Il Park | - |
dc.contributor.affiliatedAuthor | Jangwon Kim | - |
dc.contributor.affiliatedAuthor | Taeg Hwan Hyeon | - |
dc.identifier.doi | 10.1039/c4ra06628f | - |
dc.identifier.bibliographicCitation | RSC ADVANCES, v.4, no.86, pp.45687 - 45695 | - |
dc.relation.isPartOf | RSC ADVANCES | - |
dc.citation.title | RSC ADVANCES | - |
dc.citation.volume | 4 | - |
dc.citation.number | 86 | - |
dc.citation.startPage | 45687 | - |
dc.citation.endPage | 45695 | - |
dc.date.scptcdate | 2018-10-01 | - |
dc.description.wostc | 14 | - |
dc.description.scptc | 15 | - |
dc.description.journalClass | 1 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |